exce expect report result
morn revenu y/i y/i ex-
fx exceed estim consensu
revenu ep guidanc rang provid
manag anticip ep would around
sequenti due time bonu payout typic
season zbh print consist outlook
item impact quarterli comparison includ fx
headwind versu estim sell
day like estim tailwind quarter
one less bill day expect revers evenli
remaind year even though impact
minim weather headwind
prior year quarter zbh ex-fx organ sale growth
y/i compar came ahead
estim stack growth howev declin
versu report adjust ep
y/i exceed estim
consensu manag provid
commentari earn call schedul estimate
today dial passcod
outlook updat fx tax look
report revenu growth slightli prior
includ fx tailwind less prior
chang underli growth flat
impli revenu slightli prior
compar consensu estim
respect expect net sell day
impact full year maintain adj ep guidanc
rang y/i bracket
consensu estim respect
item adj oper margin expect remain rang
adj tax rate slightli low-end prior
rang rang
longer provid quarterli outlook may provid qualit
updat call beyond guidanc consensu estim
revenu ep respect
continu page
pleas see page rate definit import disclosur
requir analyst certif estimates/forecast
well fargo secur llc seek busi compani
cover research report result investor awar
firm may conflict interest could affect object report
investor consid report singl factor make
compani data secur llc estim reuter
ep exclud amort non-recur item
compani data secur llc estim reuter
continu previou page
segment result stack follow sale growth repres y/i ex-fx rate
versu segment zbh result stack follow
knee sale versu compar estim
growth driven sequenti improv europ middl east
africa emea america asia pacif knee price slightli wors
sequenti versu volum nice versu
like benefit continu uptak persona knee platform
off-set competit headwind us
hip sale versu compar estim
growth driven notabl acceler america asia
pacif off-set sequenti deceler emea hip price wors
versu volum tick nice versu like
benefit improv sale across key product improv suppli warsaw north
campu continu uptak product intern market suppli
sport medicin extrem trauma set sale versu
compar estim set price continu improv
versu along volum versu zbh
sequenti acceler like driven broad-bas growth across variou product
line like improv suppli sport medicin busi
spine craniomaxillofaci cmf sale versu
compar estim spine cmf price improv notabl
versu volum slightli lower sequenti versu
sequenti deceler like due impact continu sale forc
integr dis-synergi spine off-set continu uptak cmf thorac product
dental sale versu compar estim
dental price continu improv versu volum flat
versu result sequenti acceler like continu
make progress respect portfolio realign sale reorgan certain
question provid addit clariti around fundament busi exit
like direct commentari around pace recoveri addit look
commentari on-going remedi effort address issu outlin fda warn
letter statu full suppli recoveri anticip progress toward improv
suppli logist get product end user traction recent launch product persona
knee sidu shoulder timelin upcom launch updat sale forc invest
incent drive sale updat commerci strategi includ discuss product launch
cadenc custom segment sale forc special time driver oper
leverag weigh gross margin continu invest driver
ep growth especi portfolio manag drive compani weight averag
price target nc
price target base approxim cash ep estim risk thesi
includ increas invest slower procedur volum growth price pressur disrupt
integr biomet
zimmer biomet share trade discount large-cap med-tech peer group believ
discount narrow next twelv month compani benefit leadership
new commercially-driven ceo bryan hanson oper issu resolv pipelin
begin fulli appreci
warsaw indiana-bas zimmer biomet hold one world largest orthoped implant
manufactur compani global market leader billion reconstruct orthoped
implant busi hip knee implant togeth account roughli revenu
compani report sale billion
